Associate Director, Regulatory Affairs jobs in United States
cer-icon
Apply on Employer Site
company-logo

Navigator Medicines, Inc. · 9 hours ago

Associate Director, Regulatory Affairs

Navigator Medicines is a clinical-stage biopharmaceutical company focused on advancing biologics for targeted immune regulation. The Associate Director, Regulatory Affairs is responsible for developing regulatory strategies, ensuring compliance with FDA and global expectations, and supporting the clinical trial application approval process.

BiotechnologyLife Science

Responsibilities

Creating innovative global regulatory strategies for biologics throughout assigned product's lifecycle
Collaborating with cross-functional teams to ensure regulatory strategies align with corporate goals and evolving regulatory expectations
Ensuring regulatory compliance with evolving FDA and global regulatory expectations
Provides strategic input on regulatory requirements, including benefit/risk assessments, and recommends regulatory solutions during early-to-late stage product development
Champions and cultivate a culture of quality within a diverse working environment
Brings unstoppable energy and enthusiasm to delivering top-quality results in a fast-paced, fun, and dynamic environment

Qualification

Regulatory strategy developmentRegulatory complianceFDA regulationsCross-functional collaborationCommunication skillsAttention to detailNegotiation skills

Required

Have a working knowledge of regulatory requirements specific to key regions such as the US, Canada, and EU, and have a general awareness of current global trends in Regulatory Affairs
Recognized as a leader, crew member, and possess a cross-functional collaborative skill set
Excellent oral and written communication and negotiation skills with strong attention to detail and clarity

Company

Navigator Medicines, Inc.

twittertwitter
company-logo
Navigator Medicines is a clinical-stage biotechnology company advancing bi-specific antibodies anchored in OX40L inhibition.

Funding

Current Stage
Early Stage
Total Funding
$100M
2024-08-27Series A· $100M
Company data provided by crunchbase